Case 03: Bowel Cancer
Treatment Performed
“Combined immunotherapy for cancer” was performed as treatment for advanced bowel cancer, by combining the cancer peptide vaccine therapy and a drug to inhibit immunosuppression for approximately two years.
Treatment Outcome
Slight shrinkage of the tumor
Before treatment
![](https://neoclinic-en.jp/wp/wp-content/uploads/2021/08/03_01.png)
8 weeks after treatment initiation
![](https://neoclinic-en.jp/wp/wp-content/uploads/2021/08/03_02.png)
The tumor marker decreased, and infiltration of killer T cells and helper T cells were observed.
![](https://neoclinic-en.jp/wp/wp-content/uploads/2021/05/image2.png)
![](https://neoclinic-en.jp/wp/wp-content/uploads/2021/05/image18.png)
![](https://neoclinic-en.jp/wp/wp-content/uploads/2021/05/image4.png)